Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Clindamycin price, strengths & recalls

Generic of Cleocin, Clindacin, Clindesse, Xaciato

Pharmacies pay $5.36 for 30 capsules of Clindamycin 300 mg capsule this week, and from $3.14 to $271.89 across its 10 priced strengths and forms. 52 manufacturers make it. It is in shortage (unavailable). 13 recalls are ongoing. Its official label last changed on July 10, 2026.

Unavailable13 open recallsGeneric
Pharmacies pay$5.36for 30 capsules of 300 mg capsule+2.3% in 4 weeks
Fair cash price
$16.66
Strengths
10
Makers
52
Updated
Nov 11

Clindamycin price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
75 mg capsule$0.2692$8.08 / 30 capsules+4.1%-10.6%
150 mg capsule$0.1048$3.14 / 30 capsules+1.9%-2.4%
300 mg capsule$0.1786$5.36 / 30 capsules+2.3%-1.7%
0.01 mg/mg gel$0.1362$8.17 / 60 g+4.2%-10.8%
0.01 mg/mg gel$3.63$271.89 / 75 mL+6.6%-54.7%
150 mg/mL injectionNot priced this week
150 mg/mL, 2 mL injectionNot priced this week
150 mg/mL, 4 mL injectionNot priced this week
150 mg/mL, 6 mL injectionNot priced this week
10 mg/mL lotion$0.2323$13.94 / 60 mL-5.1%-26.6%
15 mg/mL oral solution$0.1328$13.28 / 100 mL+3.1%-19.5%
10 mg/mL topical foam$1.78$89.22 / 50 g-2.5%-38.8%
10 mg/mL topical solution$0.1892$11.35 / 60 mL+5.8%-22.9%
20 mg/mL vaginal cream$1.87$74.65 / 40 g+0.4%+19.0%

The lowest cost per capsule is 150 mg capsule at $0.1048. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Brand names of clindamycin

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

In shortage27 products are short or being discontinued
12 ongoing recalls49 recalls on record, latest Sep 9, 2026

Shortages

  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)Sandoz Inc. · Available · Updated Nov 9, 2026Civica Label
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)Sandoz Inc. · Available · Updated Nov 9, 2026Civica Label
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)Sagent Pharmaceuticals · Limited Availability · Reason: Discontinuation of the manufacture of the drug · Updated Nov 6, 2026Selling through remaining short-dated inventory (Dec 2026).
  • Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)Sagent Pharmaceuticals · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 6, 2026Discontinuation of the manufacture of the drug
  • Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)Sagent Pharmaceuticals · Limited Availability · Reason: Discontinuation of the manufacture of the drug · Updated Nov 6, 2026Selling through remaining short-dated inventory (Dec 2026).
  • Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)Baxter Healthcare · Unavailable · Reason: Other · Updated Nov 3, 2026Estimated recovery: January 2027

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 49 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for clindamycin? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJuly 10, 2026
Version22 of 15
EffectiveJul 8, 2026
Read the label

Clindamycin Hydrochloride Capsules, USP

This drug has a boxed warning

WARNING

Clostridioides difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including clindamycin hydrochloride and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon, leading to overgrowth of

C. difficile.

Because clindamycin hydrochloride therapy has been associated with severe colitis which may end fatally, it should be reserved for serious infections where less toxic antimicrobial agents are inappropriate, as described in the

INDICATIONS AND USAGE section. It should not be used in patients with nonbacterial infections such as most upper respiratory tract infections.

C. difficileproduces toxins A and B, which contribute to the development of CDAD. Hypertoxin producing strains of

C. difficilecause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibacterial drug use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.

If CDAD is suspected or confirmed, ongoing antibacterial drug use not directed against

C. difficilemay need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibacterial drug treatment of

C. difficile, and surgical evaluation should be instituted as clinically indicated.

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA050615 · Pfizer
First approved
January 7, 1987 (39 years ago)
Latest approved change
November 12, 2025
Approved label
PDF, Nov 13, 2025
Generic makers
42 approved generic applications on the market

Clindamycin questions

How much does clindamycin cost without insurance?

Pharmacies pay about $5.36 for 30 capsules of clindamycin 300 mg capsule ($0.1786 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $16.66. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of clindamycin?

Clindamycin is sold as Cleocin, Clindacin, Clindesse, Xaciato. The generic has the same active ingredient and usually costs far less.

Is clindamycin in shortage?

Yes. 27 products are listed as in shortage or being discontinued (unavailable). See which ones.

Has clindamycin been recalled?

49 recalls on record, 13 ongoing. Recalls name specific lots - check yours.

When did the clindamycin label last change?

The official label was last updated on July 10, 2026 (version 22). See what changed.

Talk about clindamycin

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.